This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
News & Press: Journals

New SSC Recommendations Released by JTH

Tuesday, August 23, 2016   (0 Comments)
Share |

The Journal of Thrombosis and Haemostasis (JTH) has accepted the following articles on recommendations from the Scientific and Standardization Committee (SSC) of the ISTH:

Subcommittee on Factor VIII, Factor IX & Rare Coagulation Disorder: Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia
The scope of this recommendation is to provide guidance for reporting of inhibitor cases in previously treated patients (PTPs) with hemophilia A. This guidance is intended to improve transparency and completeness of reporting of observed events; it does not cover planning, executing or analyzing original studies aimed at the assessment of inhibitor rates. Read more.

Subcommittee on Women's Health Issue in Thrombosis and Hemostasis: Management of direct oral anticoagulants in women of childbearing potential
Many patients receiving oral anticoagulation for VTE are in their reproductive years, but the potential for reproductive toxicity of DOACs in humans in unknown, and there are no adequate data on the use of DOACs in pregnant women via maternal or paternal exposure. Accordingly, the DOAC SPCs recommend against their use in pregnancy and during breastfeeding [1-3]. However, patients may unintentionally become pregnant while taking DOAC therapy. Read more.

Membership Management Software Powered by YourMembership  ::  Legal